Company profile: ALPCO
1.1 - Company Overview
Company description
- Provider of testing solutions for scientists and healthcare professionals, delivering molecular and immunodiagnostic assays across gastroenterology, allergy/infectious disease, diabetes and obesity, bone metabolism, and antibodies/antigens. Offerings include fecal calprotectin and pancreatic elastase assays, IgE allergy testing, and multiplex PCR detecting CT/NG/MG to inform research and quality of care.
Products and services
- ALEX² Allergy Explorer Kit: Clinical laboratory-grade ALEX² Allergy Explorer Kit performs quantitative and semi-quantitative measurement of specific and total IgE in human serum and plasma for allergy evaluation
- GeneProof CT/NG/MG Multiplex PCR Kit: Multiplexed GeneProof CT/NG/MG Multiplex PCR Kit detects and distinguishes Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma genitalium in a single reaction for infectious disease testing
- Calprotectin Immunoturbidimetric Assay: Analytical-grade Calprotectin Immunoturbidimetric Assay delivers quantitative measurement of fecal calprotectin to indicate intestinal mucosal inflammation using an immunoturbidimetric method in stool specimens
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to ALPCO
SynHelix
HQ: France
Website
- Description: Provider of offerings aimed at breaking the bottleneck of biotherapeutics development by addressing the unsolved DNA constructs supply.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SynHelix company profile →
ProZyme
HQ: United States
Website
- Description: Provider of value-added reagents, kits, and platforms for improved analytical results, utilizing microbial fermentation sciences, large-scale native and recombinant purification and formulation, and assay development; also offers analytical services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ProZyme company profile →
Altar
HQ: France
Website
- Description: Provider of biotechnology solutions in automated fluidics, developing and operating proprietary technologies that bring microbes to performance suitable for commercial use. Serves customers leveraging microorganisms to produce food, feed, flavors & fragrances, cosmetics, and fuels.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Altar company profile →
Sprint Bioscience
HQ: Sweden
Website
- Description: Provider of a fragment-based, modular gene-to-lead drug discovery platform covering protein expression/purification, fragment screening, X-ray crystallography, and fragment-to-lead expansion. Develops small-molecule candidates from idea to preclinical stage for licensing. Programs: TREX1 (DISA), VRK1 (VADA, licensed to Day One Biopharmaceuticals), NNMT (NIMA). Based in Stockholm, Sweden.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sprint Bioscience company profile →
Nanalysis
HQ: Canada
Website
- Description: Provider of portable benchtop nuclear magnetic resonance (NMR) spectrometers and supporting software for biotech, pharmaceutical, research, and education applications. Offerings include 100 MHz and 60 MHz NMR spectrometers, NMReady-CONNECT for remote control/monitoring, pulse sequence design, time-based kinetics experiments, and IQ/OQ modules for performance validation and regulatory compliance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nanalysis company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for ALPCO
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to ALPCO
2.2 - Growth funds investing in similar companies to ALPCO
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for ALPCO
4.2 - Public trading comparable groups for ALPCO
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →